Skip to main content
SpringerLink
Log in

Octreotide therapy of growth hormone excess in the McCune-Albright syndrome

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lee P.A., Van Dop C., Migeon C.J. McCune-Albright Syndrome: Long-term follow-up. JAMA 256: 2980, 1986.

    Article  PubMed  CAS  Google Scholar 

  2. Cuttler L., Jackson J.A., uz-Zafar M.S., Levitsly I.L., Mellinger R.C., Frohman L.A. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J. Clin. Endocrinol. Metab 68: 1148, 1989.

    Article  PubMed  CAS  Google Scholar 

  3. Geffner M.E., Nagel R.A., Dietrich R.B., Kaplan S.A. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. J. Pediatr. 111: 740, 1987.

    Article  PubMed  CAS  Google Scholar 

  4. Abs R., Beckers A., Van de Vyver F.L., De Schepper A., Stevenaert A., Hennen G. Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia: A variant of the McCune-Albright syndrome. J. Endocrinol. Invest. 13: 671, 1990.

    Article  PubMed  CAS  Google Scholar 

  5. Hamilton C.R., Maloof F. Unusual types of hyperthyroidism. Medicine 52: 195, 1973.

    Article  PubMed  Google Scholar 

  6. Frohman L.A., Thominet J.L., Webb C.B., Vance M.L., Uderman H., Rivier J., Vale W., Thorner M.O. Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man. J. Clin. Invest. 73: 1304, 1984.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Kourides I.A., Weintraub B.D., Levko M.A., Maloof F. Alpha and beta subunits of human thyrotropin: Purification and development of specific radioimmunoassay. Endocrinology 94: 411, 1974.

    Article  Google Scholar 

  8. Steinbach H.L. Russell W. Measurement of the heel-pad as an aid to diagnosis of acromegaly. Radiology 82: 418, 1964.

    Google Scholar 

  9. Kleinberg D.L. Young I.S., Kupperman H.S. The sesamoid index: An aid in the diagnosis of acromegaly. Ann. Intern. Med. 64: 1075, 1966.

    Article  PubMed  CAS  Google Scholar 

  10. Albright F., Butler A.M., Hampton A.O., Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunctional with precocious puberty in females. N. Engl. J. Med. 216: 727, 1937.

    Article  Google Scholar 

  11. MacMahon H.E. Albright’s syndrome — thirty years later (polyostotic fibrous dysplasia). In: Somers S.C. (Ed.) Pathology Annual. Appleton-Century-Croft, New York 1971, p.p. 6-81-147.

    Google Scholar 

  12. Lamberg B.A., Pelkonen R., Aro A., Grahne B. Thyroid function in acromegaly before and after transphenoidal hypophysectomy followed by cryoapplication. Acta Endocrinol. (Copenh.) 82: 254, 1976.

    CAS  Google Scholar 

  13. Vance M.L., Borges J.L.C., Kaiser D.L., Evans W.S., Furlanetto R., Thorninet J.L., Frohman L.A., Rogol A.D., MacLeod R.M., Bloom S., Rivier J., Vale W., Thorner M.O. Human pancreatic tumor growth hormone-releasing factor: Dose response relationships in normal man. J. Clin. Endocrinol. Metab. 58: 838, 1984.

    Article  PubMed  CAS  Google Scholar 

  14. Shibasaki T., Hotta M., Masuda A., Imaki T., Obara N., Hizuka N., Takano K. Wakabayashi L., Demura H.L., Ling N., Shizume K. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. J. Clin. Endocinol. Metab. 63: 167, 1986.

    Article  CAS  Google Scholar 

  15. Scurry M.T., Bicknell J.M., Fajans S.S. Polyostotic fibrous dysplasia and acromegaly. Arch. Intern. Med. 114: 40, 1964.

    Article  PubMed  CAS  Google Scholar 

  16. Lightner E.S., Penny R., Frasier S.D. Growth hormone excess and sexual precocity in polystotic fibrous dysplasia (McCune-Albright syndrome): Evidence for abnormal hypothalamic function. J. Pediatr. 87: 922, 1975.

    Article  PubMed  CAS  Google Scholar 

  17. Lightner E.S., Penny R., Frasier S.D. Pituitary adenoma in McCune-Albright syndrome: Follow-up information. [Letter] J. Pediatr. 89:159, 1976.

    Article  PubMed  CAS  Google Scholar 

  18. Joishy S.K., Morrow L.B. McCune-Albright syndrome associated with a functioning pituitary chromophobe adenoma. J. Pediatr. 89: 73, 1976.

    Article  PubMed  CAS  Google Scholar 

  19. Powell D.G.B. Polyostotic fibrous dysplasia with acromegaly (Albright’s syndrome): A case report. S. Afr. Med. J. 50: 182, 1976.

    PubMed  CAS  Google Scholar 

  20. Carr D., Mathie I.K., Manners A.R., Colman C. Hyperprolactinemia in a patient with the McCune-Albright syndrome. Br. J. Obstet. Gynecol. 86: 330, 1979.

    Article  CAS  Google Scholar 

  21. Albin J., Wu R. Abnormal hypothalamic-pituitary function in polyostotic fibrous dysplasia. Clin. Endocrinol. (Oxf.) 14: 435, 1981.

    Article  CAS  Google Scholar 

  22. Lipson A., Hsu T.H. The Albright syndrome associated with acromegaly Report of a case and review of the literature. Johns Hopkins Med. J. 149: 10, 1981.

    PubMed  CAS  Google Scholar 

  23. Polychronakos C., Tsoukas G., Ducharme J.R., Letarte J., Collu R. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (McCune-Albright syndrome). J. Endocrinol. Invest. 5: 323, 1982.

    Article  PubMed  CAS  Google Scholar 

  24. Chung K.F., Alaghband-Zadeh J., Guz A. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Am. J. Dis. Child. 137: 134, 1983.

    Article  PubMed  CAS  Google Scholar 

  25. Hall M.B., Sclar A.G., Gardner D.F. Albright’s syndrome with reactivation of fibrous dysplasia secondary to pituitary adenoma and further complicated by osteogenic sarcoma. Oral. Surg. 57: 616, 1984.

    Article  PubMed  CAS  Google Scholar 

  26. Kovacs K., Horvath E., Thorner M.O., Rogol A.D. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virchows Archirv. (Pathol. Anat.) 403: 77, 1984.

    Article  CAS  Google Scholar 

  27. Nakagawa H., Nagasaka A., Sugiura T., Nakagawa K., Yabe Y., Nihei N., Hirooka M., Itoh M., Nakai A., Ohyama T., Aono T., Gerich J.E. Gigantism associated with McCune-Albright’s syndrome. Horm. Metab. Res. 17: 522, 1985.

    Article  PubMed  CAS  Google Scholar 

  28. Harris R.I. Polyostotic fibrous dysplasia with acromegaly. Am. J. Med. 78: 539, 1985.

    Article  PubMed  CAS  Google Scholar 

  29. Mauras N., Blizzard R.M. The McCune-Albright syndrome. Acta Endocrinol. (Copehn.) 279 (Suppl.): 207, 1986.

    CAS  Google Scholar 

  30. Pacini F., Perri G., Bagnolesi P., Cilotti A., Pinchera A. McCune-Albright syndrome with gigantism and hyperprolactinemia. J. Endocrinol. Invest 10: 417, 1987.

    Article  PubMed  CAS  Google Scholar 

  31. Misaki M., Shima T., Ikoma J., Morioka K., Suzuki S. Acromegaly and hyperthyroidism associated with McCune-Albright syndrome. Horm. Res. 30:26, 1988.

    Article  PubMed  CAS  Google Scholar 

  32. Pun K.K., Chan G., Kung A., Lam K., Chan F.L., Wang C. McCune-Albright syndrome with acromegaly. Horm. Metab. Res. 21: 527, 1989.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Blalock 904, 600 North Wolfe Street, Baltimore, Maryland, 21205, USA

    S. I. Sherman & P. W. Ladenson

Authors
  1. S. I. Sherman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. W. Ladenson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sherman, S.I., Ladenson, P.W. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. J Endocrinol Invest 15, 185–190 (1992). https://doi.org/10.1007/BF03348702

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348702

Key-words

Search

Navigation